IDEX (NYSE:IEX – Get Free Report) announced its quarterly earnings data on Wednesday. The industrial products company reported $2.10 EPS for the quarter, beating analysts’ consensus estimates of $2.04 by $0.06, FiscalAI reports. The company had revenue of $899.10 million during the quarter, compared to the consensus estimate of $882.00 million. IDEX had a return on equity of 15.03% and a net margin of 13.98%.The company’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.04 EPS. IDEX updated its Q1 2026 guidance to 1.730-1.780 EPS and its FY 2026 guidance to 8.150-8.35 EPS.
Here are the key takeaways from IDEX’s conference call:
- IDEX’s Health & Science Technologies (HST) segment showed strong momentum with 34% organic orders growth in Q4, ~$493M in segment orders and broad demand in data-center, semiconductor, space/defense and related applications, giving management higher conviction for HST into 2026.
- The company reported better-than-expected Q4 results with adjusted EBITDA margin +40 bps, an adjusted EPS beat, and strong cash generation — $617M free cash flow for FY‑2025 (103% conversion), ~$1.1B liquidity and ~$250M of share repurchases in 2025.
- 2026 guidance is modestly paced: organic growth 1%–2%, adjusted EBITDA margin targeted at 26.5%–27% and adjusted EPS of $8.15–$8.35, reflecting mid-single-digit HST growth offset by flat-to-down FMT and FSDP.
- Industrial-facing segments remain soft — FMT saw only +4% orders/+1% sales and FSDP had flat orders and -5% sales, with ongoing weakness in chemicals, energy, agriculture and international fire & safety demand and no clear macro inflection yet.
- Capital allocation remains shareholder-friendly and disciplined: focus on tuck‑in M&A (integrating Micro‑LAM), maintaining investment‑grade leverage, a dividend target of 30%–35% of adjusted net income, and a base repurchase cadence (~$75M/quarter assumption).
IDEX Price Performance
NYSE:IEX opened at $212.62 on Friday. The company has a market capitalization of $15.91 billion, a price-to-earnings ratio of 33.17, a PEG ratio of 2.14 and a beta of 1.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.06 and a current ratio of 2.86. IDEX has a 52 week low of $153.36 and a 52 week high of $213.83. The company has a 50-day moving average of $185.80 and a 200-day moving average of $173.06.
IDEX Announces Dividend
Wall Street Analysts Forecast Growth
Several brokerages have commented on IEX. TD Cowen raised their target price on shares of IDEX from $200.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday. Oppenheimer reaffirmed an “outperform” rating and issued a $230.00 target price on shares of IDEX in a research report on Thursday. Royal Bank Of Canada boosted their price objective on shares of IDEX from $211.00 to $244.00 and gave the company an “outperform” rating in a research report on Thursday. Stifel Nicolaus lifted their target price on shares of IDEX from $200.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, January 23rd. Finally, DA Davidson increased their price objective on IDEX from $180.00 to $195.00 and gave the stock a “neutral” rating in a report on Thursday. Six investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.22.
Read Our Latest Research Report on IDEX
Institutional Trading of IDEX
Several large investors have recently added to or reduced their stakes in the company. CYBER HORNET ETFs LLC bought a new stake in shares of IDEX during the second quarter valued at approximately $35,000. MUFG Securities EMEA plc bought a new stake in IDEX in the second quarter valued at approximately $39,000. Employees Retirement System of Texas acquired a new position in IDEX in the third quarter valued at about $99,000. Advisory Services Network LLC acquired a new position in shares of IDEX in the 3rd quarter valued at approximately $105,000. Finally, Parallel Advisors LLC boosted its holdings in shares of IDEX by 18.6% in the third quarter. Parallel Advisors LLC now owns 664 shares of the industrial products company’s stock valued at $108,000 after buying an additional 104 shares during the period. 97.96% of the stock is owned by institutional investors.
About IDEX
IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.
Operations at IDEX are organized into three principal segments.
Further Reading
- Five stocks we like better than IDEX
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- Nervous about the stock market? Read this
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.
